Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Oct 14;193:110312. doi: 10.1016/j.envres.2020.110312

Antiviral activity of natural humic substances and shilajit materials against HIV-1: Relation to structure

Yury V Zhernov a, Andrey I Konstantinov b, Alexander Zherebker c, Eugene Nikolaev c, Alexey Orlov c, Mikhail I Savinykh d, Galina V Kornilaeva e, Eduard V Karamov e, Irina V Perminova b,
PMCID: PMC7554000  PMID: 33065073

Abstract

Natural products, such as humic substances (HS) and shilajit, are known to possess antiviral activity. Humic-like components are often called as carriers of biological activity of shilajit. The goal of this study was to evaluate anti-HIV activity of well characterized HS isolated from coal, peat, and peloids, and compare it to that of water-soluble organic matter (OM) isolated from different samples of Shilajit. The set of humic materials included 16 samples of different fractional composition: humic acid (HA), hymatomelanic acid (HMA), fulvic acid (FA). The set of shilajit OM included 19 samples of different geographic origin and level of alteration. The HIV-1 p24 antigen assay and cell viability test were used for assessment of antiviral activity. The HIV-1 Bru strain was used to infect CEM-SS cells. The obtained EC50 values varied from 0.37 to 1.4 mg L−1 for the humic materials, and from 14 to 142 mg L−1 for the shilajit OM. Hence, all humic materials used in this study outcompeted largely the shilajit materials with respect to anti-HIV activity: For the humic materials, the structure-activity relationships revealed strong correlation between the EC50 values and the content of aromatic carbon indicating the most important role of aromatic structures. For shilajit OM, the reverse relationship was obtained indicating the different mechanism of shilajit activity. The FTICRMS molecular assignments were used for ChEMBL data mining in search of the active humic molecules. As potential carriers of antiviral activity were identified aromatic structures with alkyl substituents, terpenoids, N-containing analogs of typical flavonoids, and aza-podophyllotoxins. The conclusion was made that the typical humic materials and Shilajit differ greatly in molecular composition, and the humic materials have substantial preferences as a natural source of antiviral agents as compared to shilajit.

Keywords: Humic acid, Fulvic acid, Shilajit, Antiviral, HIV, Structure-activity, 13C NMR, FTICR MS, ChemBL data-mining

Highlights

  • Comparison of anti-HIV activity measured for the two large sets of humic materials and Shilajit water extracts demonstrated much higher activity of the humic materials.

  • Structure-activity relationships revealed leading role of aromatic structures in anti-HIV activity of humic substances, and the opposite trend was observed for shilajit.

  • 13C NMR and FTICR MS studies revealed structural similarity of shilajit extract to fulvic acid.

  • Different mode of antiviral action is suggested for aromatics-rich humic materials (humic acids, hymatomelanic acids) and N-rich shilajit.

List of abbreviations

AZT

Azidothymidine

CC50

50% cytotoxic concentration

CHA

Coal humic acids

CHG

Coal gray humic acid

ChEMBL

a manually curated database of bioactive molecules with drug-like properties

EC50

50% effective concentration

FA

Fulvic acid

HA

Humic acid

HCMV

Human cytomegalovirus

HIV

Human immunodeficiency virus

HMA

Hymatomelanic acid

HS

Humic substances

HSV-1

Herpes simplex virus-1

HSV-2

Herpes simplex virus-2

MOI

Multiplicity of infection

PAs

Polyanions

PelHA

Peloid humic acid

PelFA

Peloid fulvic acid

PelHMA

Peloid hymatomelanic acid

PFA

Peat fulvic acid

PHA

Peat humic acid

RAL

Raltegravir

RSV

Respiratory syncytial virus

RTI

Reverse transcriptase inhibition

SI

Selectivity index

SM

Shilajit materials

TBEV

Tick-borne encephalitis virus

1. Introduction

Fast evolution and mutation of viruses set forward a need for new antiviral agents suitable for treatment of drug-resistant infections. The multiple strains of the influenza viruses show resistance to adamantane derivatives (Dong et al., 2015), the herpes virus family – to acyclovir (Pottage et al., 1995), retroviruses – to azithromycin (Jeeninga et al., 2001). Due to a vast genetic diversity, the human immunodeficiency virus (HIV) develops quickly the resistance to monomolecular antiretroviral drugs (Karamov et al., 2018; Moskaleychik et al., 2015). Moreover, the pandemy of COVID-19, which hit already more than 5 million people globally, shows how limited a pool of antiviral drugs is (Dong et al., 2020; Ford et al., 2020; Li and De Clercq, 2020). In this respect, the natural supramolecular systems of biologically active compounds might be of particular value. Humic substances (HS) have been known for a long time for their antiviral activity (Helbig et al., 1997; Jooné et al., 2003; Klöcking et al., 2002). The different fractions of natural HS and synthetic HS-like materials are active against HIV (Botes et al., 2002; Brucolleri et al., 2013; Kornilaeva et al., 2019; Schneider et al., 1996; Van Rensburg et al., 2002; Zhernov et al., 2017; Zhernov, 2018), influenza virus A/WSN/1933 (H1N1) (Lu et al., 2002), herpes simplex virus-1 (HSV-1) (Klöcking et al., 2002), Coxsackie virus A9 (Klöcking et al., 1972), tick-borne encephalitis virus (TBEV) (Orlov et al., 2019).

HS are the products of deep chemical and microbial oxidation of bioprecursors – lignins, tannins, peptides, cellulose, lipids, terpenoids, released from the remnants of plants and animals (Stevenson, 1994). These oxidized biomolecular precursors are assembled into supramolecular multicomponent systems of carboxyl and hydroxyl rich molecules. Given the presence of extended carbon backbone in these molecules, they can be considered as carboxylated polyanions (PAs). The latter have been intensively studied as components of microbicides aimed at prophylactics of viral infections (Zhernov and Khaitov, 2019; Zhan et al., 2016; Andrae-Marobela et al., 2013; Daglia, 2012). Shialit is another natural biologically active material, which is commonly used in traditional medicine (Agarwal et al., 2007). It is represented by brown to blackish-brown resinous matter found in the different mountain regions and considered to be a complex product of biotransformation of plant residues (Agarwal et al., 2007). Shilajit was reported as a dose-dependent inhibitor against HSV-1, HSV-2, human cytomegalovirus (HCMV), and respiratory syncytial virus (RSV) (Cagno et al., 2015). These are humic-like components, which are suggested to provide for multiple therapeutic properties of Shilajit (Schepetkin et al. 2003, 2009). However, the studies on direct comparison of the biological activity of HS from different sources (e.g., soil. peat, coal) and shilajit, as well as on the corresponding structure-activity relationships, are missing.

In our previous study on the anti-HIV activity of HS isolated from peloids (fresh water bottom sediments), we observed that the strongest inhibiting activity was characteristic of the most hydrophobic fractions of humic (HA) and hymatomelanic acids (HMA) (Zhernov et al., 2017). The most hydrophilic fraction of fulvic acid (FA) had the least activity. The structure-activity analysis revealed direct relationship between antiviral activity and the ratio of aromatic to aliphatic structures (lipophilicity index) of the different humic fractions used, and the inverse relationship with their carboxylic and total acidity. Given these previous results, we expanded largely the set of HS samples on the account of the most hydrophobic natural HS isolated from coal and peat. In addition, we included a broad set of crude shilajit samples to facilitate a direct comparison of biological activity of these two different natural products.

2. Materials and methods

2.1. Humic and shilajit materials used in this study

A set of humic and humic-like materials included 16 fractionated HS samples (HA, FA, HMA, as well as gray humic acid (CHG) from natural sources (coal, peat, peloid), one sample of oxidized lignin, and one sample of synthetic FA. Four samples of coal humic acids (CHA) were isolated by precipitation with acid followed by dialysis from the commercially available samples of potassium humates (Powhumus, Irkutsk Humate, Sakhalin Humate, Activated Humic Acid) and designated as (CHA-P), (CHA-I), (CHA-S), and CHA-A, respectively. One sample was isolated from lignite of the Baikal region (CHA-G) using alkali extraction (0.3 M NaOH). Peat HS included highmoor humic acid (PHA-T) and fulvic acid (PFA-5); lowmoor non-fractionated HS (PHF-1), and humic acid (PHA-1, PHA-3). Peloid humic materials were extracted from bottom sediments of the Molochka lake in Samara region and included humic acid (PelHA), fulvic acid (PelFA) and hymatomelanic acid (PelHMA). Peloid HS were extracted and fractionated according to the scheme described in our previous publication (Zhernov et al., 2017). The samples set also included veterinary pharmaceutical drug Ligfolum produced from the oxidized lignin, and a fulvic-like fraction of synthetic HS (MHQ-FA) synthesized via oxidative polymerization of phenols as described by (Zherebker et al., 2015). The latter represented a structural analogue of HS with the known molecular features.

Seventeen samples of raw shilajit materials originated from the different geographic regions (the Altai mountains in Russia and Mongolia, the Aldan river basin in Yakutia, Central Asia, the Caucasus). They were homogenised and dissolved in distilled water. Water extracts were centrifuged to separate insoluble part, and dried in a vacuum oven at temperature of 45 °C. This way 17 samples of shilajit mateials (SM) were prepared. The set of samples also included Altai “Golden mumiyo” (Sh-Alt, Russia) and Himalayan “Shilajit Dabur” (Sh-Him, India) pharmaceutical shilajit preparations.

The full set of humic and shilajit materials used in this study, along with their CHNO elemental compositions are listed in Table S1 in Supplementary Material.

2.2. Structural characterization of the HS and shilajit materials

13C NMR spectra were acquired using a Bruker Avance 400 NMR spectrometer operating at 400 MHz proton frequency. All humic and shilajit solutions were prepared as following: a weight of 45 mg of a sample was dissolved in 0.6 mL of 0.3M NaOD/D2O with isotope purity of 99+% (Aldrich). For suppressing the nuclear Overhauser effect, the broadband decoupling from protons was switched off for the relaxation delay time. The relaxation time delay was 7.8 s in accordance with the conditions described by (Kovalevski et al., 2000). The NMR assignments were made after (Hertkorn et al., 2002): carbon of alkyl chains (CHn) – 0–50 ppm; carbon of alkoxide groups CH3O – 50–58 ppm, CH2O – 58–65 ppm, CHO – 65–90 ppm, and OCO – 90–110 ppm; aromatic carbon bonded with H or C atoms (Car) – 110–145 ppm; aromatic carbon bonded with oxygen (CarO) – 145–165 ppm; carbon of carboxylic groups (COO) – 165–187 ppm; carbon of carbonyl groups (C Created by potrace 1.16, written by Peter Selinger 2001-2019 O) – 187–220 ppm. In case of shilajit samples characterized with significant content of nitrogen (see Table S3 in Supplementary Material), the spectral intervals of 50–65 and 165–187 ppm were also attributed, respectively, to CH–N groups of amino acids and to amide structures (CO–N).

2.3. Compilation of the FTICR MS data set for the HS and shilajit materials

For characterization of molecular space of the set of HS samples used in this study the previously published FTICR mass-spectrometric data (peak lists) were used for CHA-G, CHA-P, CHA-S, PelHA, PelHMA, PekFA, PHA-5, PFA-5, MHQ-FA were used (Orlov et al., 2019; Zhernov et al., 2017). Mass-spectrum of the Shelajit sample Sh1 was obtained using 7T FTICR MS Apex Ultra (Bruker Daltonics, Germaby) equipped with the harmonized cell (Nikolaev et al., 2011) and electrospray ionization (ESI) source operating in negative ion mode. The spectra were acquired with a time domain of 4 megawords in ESI (−) and 300 scans were accumulated for each spectrum. Resolving power was 530 000 at m/z = 400. Here all spectra were first externally calibrated using the synthesized carboxylated polystyrene as described previously (Zherebker et al., 2017), followed by internal calibration using fatty acids residual signals (Sleighter et al., 2008) which yielded accuracy values < 0.5 ppm. Only peaks with a signal to noise (S/N) ratio exceeding 6 were used for formulae assignment.

Molecular compositions were assigned using the open source browser-based application UltraMassExplorer created by Leefmann et al. (http://dockersrv1.awi.de:3838/ume) (Leefmann et al., 2019). The pivot table with all assigned formulae is presented in Supplementary file Table S5. The generated CHONS formulas were validated by setting sensible chemical constraints typical for DOM (O/C ratio ≤ 1, 0.3<H/C ratio ≤ 2.2, element counts (C ≤ 120, H ≤ 200, 0<O ≤ 60, N ≤ 2, S ≤ 1) and mass accuracy window < 0.5 ppm) (Kunenkov et al., 2009; Sleighter et al., 2007). Additionally, for HS only formulae presenting in at least two samples were considered. All formulae were further divided into three categories according to a modified aromaticity index (AImod) proposed by (Koch et al., 2016) AImod was calculated according to the following equation (1):

AImod=1+C0.5OS0.5(N+H)C0.5ONS (1)

where C, H, O, N, S are the numbers of atoms in molecular formulae.

2.4. HIV-1 p24 antigen assay and cell viability test

The HIV-1 Bru strain was used in this study to infect CEM-SS cells which were derived from the human lymphoblastoid cell line CEM that expresses high levels of the CD4 antigen (Wain-Hobson et al., 1991). The cells were cultured in the suspension medium RPMI-1640 (Gibco) containing 10% FCS. The CEM-SS cells were cultured at a density of 7.0 × 104/well and infected with HIVBRU at the multiplicity of infection (MOI) of 1. All solutions of the HS and shilajit samples were sterilized using 0.22 μm syringe-filters (Merck Millipore Ltd) and stored at −20 °C until use. CEM-SS cells were incubated for 24 h in the absence and presence of HS and SM samples in 96-well plates. The HS and shilajit samples were homogeneous and stable throughout the incubation period in a 96-well plate. As a control, we used the reference HIV-1 inhibitors: the reverse transcriptase inhibitor Azidothymidine (AZT) and the integrase inhibitor Raltegravir (RAL). They were purchased from Sigma-Aldrich. After 3 days following three washings, CEM-SS cells were cultured in 96 well plates for 3 days to measure p24 release. The level of virus replication was detected by ELISA using a «HIV-1 p24 antigen-ELISA-BEST » test system (Vector-Best, Novosibirsk, Russia). The effects on cell viability were monitored by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay, which measures the reduction of yellow MTT to purple formazan by mitochondrial enzymes (Mosmann, 1983).

2.5. Statistical analyses

EC50 and CC50 values were calculated using GraphPad Prism v.5.00 software (GraphPad Software, La Jolla, CA). The approximation for sigmoidal dose-response was used with variable slope by setting the following constraints: fixed top of 100, and fixed bottom of 0. As internal acceptance criteria, R2 values were set to ≥0.9. The therapeutic value of the drug was estimated using the selectivity index (SI). It is calculated as a ratio of 50% cytotoxic concentration (CC50) to 50% effective concentration (EC50). Statistical significance was determined using one-way Anova with the Bonferroni post hoc test (p < 0.0001).

2.6. ChEMBL data mining and analysis

ChEMBL data retrieval was performed similarly to the previously developed pipeline (Orlov et al., 2019; Fedoros et al., 2018). MySQL edition of ChEMBL26 was used for data mining. Briefly, ChEMBL dump file was put into a local MySQL database. All molregno and canonical_smiles entries were extracted from compound_structures table. Entries of canonical_smiles field containing disconnected fragments (entries containing “.” symbol) were additionally preprocessed in the following way. All entries were split at ‘.’ symbol and the largest SMILES substring was kept. Compounds corresponding to these SMILES were further neutralized using RDKit (RDKit: Open-source chemoinformatics; http://www.rdkit.org). rdMolStandardize module and formulae for all found compounds were generated using RDKit. Then the formulae of the samples with the Spearman rank correlation coefficient with EC50 lower or equal to −0.7 (339 formulae) were searched among all formulae from the ChEMBL data base. The data on compound structures (compound_structures), activities (activities), bioassays (assays), etc. were extracted from ChEMBL. To retrieve the activity entries relevant to HIV, case insensitive substring query searching using ‘HIV’ and ‘human immunodeficiency’ strings was performed in assays.description and assays.organism, assays.mc_organism fields. All extracted entries were manually analyzed.Network-based representation was constructed using DataWarrior (v.5.2.1) software (Sander et al., 2015). Stereo-depleted SMILES strings were used for the calculation of DataWarrior's FragFP fingerprints and network building. Tanimoto index cut-off was set to 0.8. Thus, each network node corresponds to the structure (with removed stereochemistry information) and edge corresponds to structural similarity index above cut-off.

3. Results and discussion

3.1. Antiviral activity and cytotoxicity of the humic and shilajit materials used in this study

The cytotoxicity of the humic and shilajit samples with respect to the CEM-SS cells was assessed using MTT assay. For the majority of the humic and shilajit samples at a concentration of 1000 mg L−1, the mitochondrial activity was above 80%. Ligfolum exhibited low toxicity (CC50 = 708 mg L−1). The FA samples under study at a concentration of 1000 mg L−1 also caused a decrease in mitochondrial activity below 80%, but it was still above 70%. The obtained results are indicative of good safety profile both for humic and shilajit materials used in this study.

The typical dose-inhibition curves against HIV-1 infection for the humic and shilajit materials of different origin and/or fractional composition are shown in Fig. 1 . The full set of the EC50 values obtained for the humic and Shilajit samples used in this study is summarized in Table 1 . It can be seen that the humic materials were characterized with much higher inhibitory activity with respect to HIV-1 replication in CEM-SS cells as compared to the water extracts of Shilajit samples used in this study. The EC50 values of humic materials (Table 1) ranged from 0.37 to 1.41 mg L−1, whereas for the of shilajit samples they did not exceed 14 mg·L− 1.

Fig. 1.

Fig. 1

The typical dose-inhibition curves for the humic and shilajit materials from different sources and/or fractional composition (n = 3; R2˃0.9). The samples are highlighted as follows: coal HA (red), peloid FA (violet), peat HA (orange), peloid HMA (green), non-altered Sh (black), altered Sh (brown), Ligfolum (blue). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Table 1.

The antiviral activity of the humic and shilajit materials used in this study.

Humic samples Source EC50 (mg·L−1)a Shilajit samples Description EC50 (mg·L−1)c
CHA-G Coal 0.37 ± 0.03 Sh1 Black and rust-colored, altered, Altai 97.69 ± 0.44
CHA-S Coal 0.43 ± 0.03 Sh3 Black and rust-colored, altered, Aldan 54.63 ± 0.64
CHG-P Coal 0.53 ± 0.05 Sh4 Blackish-brown, altered, Altai 103.2 ± 0.2
CHA-P Coal 0.53 ± 0.03 Sh6 Blackish-brown, altered, Altai 99.23 ± 0.29
CHA-A Coal 0.69 ± 0.06 Sh7 Brown, altered, Altai 104.2 ± 0.21
CHA-I Coal 0.72 ± 0.04 Sh9 Black, low altered, Altai 48.84 ± 0.41
PelHMA Peloid 0.45 ± 0.06 Sh13 Blackish-brown, altered, Altai 38.78 ± 0.4
PelHA Peloid 0.58 ± 0.02 Sh15 Yellow-brown, altered, Pamir 96.95 ± 0.64
PelHFA Peloid 1.00 ± 0.06 Sh18 Blackish-brown, altered, Altai 60.81 ± 0.44
Ligfolum Oxidized lignin 0.96 ± 0.11 Sh19 Blackish-brown, altered, Central Asia 26.13 ± 0.21
PHA-5 Peat 0.80 ± 0.03 Sh20 Blackish-brown, altered, Altai 98.85 ± 0.41
PHF-1 Peat 1.13 ± 0.03 Sh22 Blackish-brown, altered, Altai 40.1 ± 0.48
PHF-3 Peat 1.14 ± 0.03 Sh25 Black, low altered, Altai 110.1 ± 0.32
PHA-1 Peat 1.20 ± 0.04 Sh29 Black, low altered, Afganistan 14.03 ± 0.62
PHA-3 Peat 1.22 ± 0.03 Sh30 Black, low altered, Afganistan 54.12 ± 0.36
Fulvic samples Source EC50 (mg·L−1)b Sh32 Black, altered, Caucasus 90.6 ± 0.67
PFA-5 Peat 1.27 ± 0.01 Sh38 Black, low altered, Altai 81.06 ± 0.41
MHQ-FA Synthetic FA 1.27 ± 0.02 Sh-Alt Pharmaceutical drug, Altai 44.74 ± 0.22
PelFA Peloid 1.41 ± 0.04 Sh-Him Pharmaceutical drug, Himalayas 48.0 ± 0.1
a

M±SD, n = 3 (CC50 > 1000 mg L−1 for all studied humic acid samples).

b

M±SD, n = 3 (CC50 > 500 mg L−1 for all studied fulvic acid samples).

c

M±SD, n = 3 (CC50 > 200 mg L−1 for all studied shilajit samples).

The highest activity was observed for the most hydrophobic and aromatic enriched coal humic acids. The comparable activity was characteristic for the peloid humic acids and hymatomelanic acid. Peat HA had intermediary activity, and the lowest activity was observed for low molecular weight oxidized FA is significantly lower. At the same time all Shilajit samples had the least activity. The altered shilajit samples were characterized with the higher activity as compared to the non-altered ones.

The EC50 values measured for coal and peloid HA and HMA ranged from 0.37 to 0.72 mg L−1 outcompeting the oxidized lignin sample Ligfolum (0.96 ± 0.11 mg L−1). The reference HIV-1 inhibitors predictably showed better activity than the HS samples used in this study: The EC50 values determined for AZT and RAL were 5.5 and 3.4 ng L−1, respectively. Some of the EC50 values found for coal and peloid HA were even lower than the best reported values for the synthetic carboxylated polyanions (PA) (0.76–0.97 mg L−1) (Leydet et al., 1998; Savage et al., 2014; Schols et al., 1991) indicating high activity of the humic materials used in this study, which can be treated as humic PAs. The EC50 value of the highmoor peat HA (PHA-5) (0.79 mg L−1) was close to coal HA, whereas the corresponding values for the lowmoor HA and non-fractionated HS were in the range from 1.13 to 1.22 mg L−1. The EC50 values of all FA samples ranged from 1.26 to 1.41 mg L−1. The similar activity had the synthetic FA (MHQ-FA) (1.27 mg L−1). It should be noted that this synthetic FA was obtained by oxidative polycondensation of hydroquinone with model phenylpropanoic acid (Zherebker et al., 2015). It was enriched with aliphatic, carboxyl and OCO fragments despite the aromatic nature of the monomers. The carbon distribution in this sample was characteristic of fulvic acids, for example, PFA. This might be indicative of lower activity of more oxidized, hydrophilic, low molecular weight humic materials (e.g., FA fractions) as compared to more hydrophobic, enriched with aromatic structures humic materials (e.g., HA, HMA, gray HA fractions).

For better visualization of the differences in anti-HIV properties between humic and Shilajit materials, we plotted all EC50 values and selectivity index (SI) values in Fig. 2 . The clustering of shilajit materials is visible in Fig. 2B: three groups of shilajit materials can be distinguished with similar activity within the cluster (each cluster is marked with different colors). All 19 shilajit samples used in this study were characterized with two orders of magnitude lower anti-HIV activity as compared to the humic materials (Fig. 2B, Table 1). The EC50 values measured for the shilajit samples ranged from 14 to 142 mg L−1. The selectivity index (SI) for all studied samples of the shilajit (except for Sh29 sample) did not exceed 10. Even the EC50 values of the least active samples of FA were an order of magnitude lower (the activity higher) as compared to the most active sample of shilajit. Still, there was substantial variation observed within the shilajit samples. The highest activity was observed in the black, least altered samples of shilajit, while the least activity was observed in the weathered (brownish to yellowish samples of shilajit).

Fig. 2.

Fig. 2

The humic (A) and shilajit (B) materials clustering based on SI and EC50: (A) blue squares – HA from coal; green triangles – HA, HMA and HFA from peloid, red rhombuses – HA and HFA from peat, purple square – oxidized lignin, orange hexagon – FA of various sources of origin. (B) Green, red, and blue colors are shown separating different array clusters of shilajit samples. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

3.2. Structure-antiviral activity relationships derived from 13C NMR data on the humic and shilajit materials used in this study

In order to reveal the relationship between anti-HIV activity and structural features of the humic and shilajit materials used in this study, their structural composition was determined with a use of quantitative solution-state 13C NMR spectroscopy. The 13C NMR spectra of the HS samples under study were typical of HS represented by broad, highly overlapped signals (Fig. 3 a,b).

Fig. 3.

Fig. 3

Typical 13C NMR spectra of coal humic acids (a), peat fulvic acids (b), and shilajit (c).

The coal HA were characterized with the presence of intense spectral band in the range of aromatic carbon (110–165 ppm), signals of alkyl chains (0–50 ppm), and carboxylic groups (165–185 ppm). The minimum intensity was observed in the range of alkoxide (predominantly, carbohydrate) structures (50–100 ppm). The peat FA were characterized with the presence of an intense signal in the range of carbohydrate structures (60–90 ppm), aromatic and carboxylic groups. The aromatic region was characterized with three distinct peaks at 115, 130 and 156 ppm: the first and second ones are characteristic of aromatic carbon in o- and p-position to hydroxy groups, the third one corresponds to Car-O carbon indicating high degree of oxidation of FA and its enrichment with OH- and COOH- groups.

13C NMR spectra of shilajit are very different from the HA-related materials (Fig. 3c). The spectra are characterized with the presence of a broad band of alkyl chains (0–50 ppm), sharp signals of carbohydrate and primary/secondary amine structures (65–90 ppm), and carboxylic groups (165–185 ppm). A distinct group of sharp peaks at 127–135 ppm, which were characteristic of all spectra of shilajit, was attributed to aromatic carbon of hippuric acid. The latter is a typical component of shilajit (Agarwal et al., 2007; Konstantinov et al., 2013). A sharp signal at 165 ppm was attributed to amide structures of peptide chains and hippuric acid. Despite the striking difference to coal HA, the 13C NMR spectra of shilajit were rather similar to the spectra of peat FA (Fig. 2b,c). Given that this study used water-extractable portion of shilajit organic matter, it should have much more in common with the acid-soluble fraction of HS - fulvic acid - as compared to the acid-insoluble humic acid. Fulvic acid is characterized with the highest contribution of oxygen-containing functions, which has some similarity with the organic matter of water-soluble fraction of shilajit.

Quantitative structural data for each sample were obtained as a set of integrals of 13C NMR spectral regions assigned to typical structural units of humic and shilajit materials. They are given in Table S2 in the SI. The highest content of aromatic carbon (Car and CarO) (from 51 to 61% of the total C) was characteristic of humic acids and their fractions isolated from coal and peloid. These samples were characterized with the lowest content of carbohydrate moieties and methoxyl groups (4–15%). On contrary, the peat humic materials and all fulvic acids used in this study were characterized with the lower content of aromatic carbon (34–39%) and much higher content of carbohydrate moieties (from 23 to 34%). The content of alkyl carbon (CHn) and carboxylic (COO) structures varied from 8 to 21% and 9–18%, respectively (see Table S3 in Supplementary Material). The shilajit samples under study were characterized with contribution of total aromatic and alkoxide (along with amino acid) structures in the range of 24–38% and 22–33%, respectively, that was similar to those measured for fulvic acids of peat. The content of alkylic and carboxylic/amide carbon ranged from 18 to 31% and from 8 to 15%, respectively (see Table S3 in Supplementary Material).

The discussed above quantitative data on structural group composition of the humic and shilajit samples were used for correlation analysis with the set of the corresponding data on antiviral activity. The obtained data are shown in Fig. 4 A and B and Figs. S1 and S2 in Supplementary Material. It can be seen that the EC50 values of the humic materials used in this study were inversely related to the content of unsubstituted aromatic carbon (Car) (r = −0,84; p = 0.00095) (Fig. 4A).

Fig. 4.

Fig. 4

The matrix of Spearman correlation coefficients for the EC50 values and the content of carbon in the different chemical environments as measured by 13C NMR spectroscopy: A) for the humic materials used in this study (n = 15); B) for the shilajit materials (n = 19).

A significant positive relationship was observed for the content of CH2O groups (r = 0.7; p = 0.004). This might be indicative of a drop in activity of the HS samples with increasing content of carbohydrates. The correlation analysis for the shilajit samples yielded the opposite trends. The strongest inverse relationship was observed with the content of CH3O & CH2O or CH–N (r = −0.63; p = 0.004). On contrary to HS, antiviral activity of shilajit was inversely related to the content of aromatic structures reflected in the positive correlation between EC50 and Car (r = 0.61; p = 0.006) (Fig. 4B). This might be indicative of the different mechanism of activity inherent within shilajit materials as compared to humic acid-dominated humic materials, e.g. coal, peat, peloids, etc. Given the substantial impact of structural group composition of both humic and shilajit samples on their antiviral activity, it was of particular interest to search for the relationships between molecular composition of HS and shilajit and their antiviral activity. The information on molecular composition is provided by FTICR MS. In this study, we had at our disposal FTICR MS data only for the subset of humic materials. This is a reason why we could conduct the respective studies only on the humic materials.

3.3. Structure-antiviral activity relationships derived for the FTICR MS data on the HS samples used in this study

For depiction of molecular composition of humic materials, we used FTICR MS data on nine (out of 16) HS samples used in this study. The amount of empirical formulae, which were present in, at least, 2 samples, ranged from 1902 to 4400. Van Krevelen diagrams for the respective HS samples are shown in Fig. 5 . One available spectrum of the shilajit sample (Sh1) is given for comparison.

Fig. 5.

Fig. 5

Van Krevelen diagrams constructed on FTICR MS data of the 9 humic materials and 1 shilajit sample under study. Colors correspond to aromaticity of molecules: black – condensed aromatics (AImod≥0,67); blue – aromatics (AImod≥0,5); red – non-aromatics (AImod<0,5). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

The dots in Van Krevelen diagrams are highlighted in different colors with respect to the value of aromaticity index (AImod). The latter is introduced to evaluate aromaticity of molecular components of complex mixtures (Koch et al., 2006): the values of AImod ≥ 0.67 and > 0.5 correspond to condensed aromatic and aromatic compounds, respectively. This representation reveals drastic difference in molecular composition of the samples used in this study: the humic acid samples from coal, peloid, and peat are dominated by condensed and aromatic compounds, whereas the fulvic acid samples (and shilajit) are characterized by maximum contribution of highly oxidized unsaturated and saturated compounds with AI below 0.5. These data corroborate well the FTICR MS results reported by Khanna et al. (2008): the authors found very similar molecular space for fulvic acids extracted from Shilajit, which was located above AI = 0.5 line. This characterizes shilajit as very hydrophilic material dominated with carbohydrates and nitrogen-containing compounds. High content of nitrogen (up to 14%) is a remarkable feature of shilajit materials which is very different from N-depleted humic materials (up to 4%) as follows from comparison of the elemental compositions of the sample sets (Table S1).

Of importance is that the first group of samples (all humic acids) is characterized with high anti-HIV activity, whereas the second group (all fulvic acids including shilajit) are characterized with low anti-HIV activity. For revealing molecular composition – anti HIV relationship, the relative intensities of the corresponding peaks in mass-spectra (Supplementary Info Table S5) were used for calculation of Spearman rank correlation with EC50. For better visualization, the data were plotted in van Krevelen diagram with color-coded correlation of molecular constituents (Fig. 6 ).

Fig. 6.

Fig. 6

Van Krevelen diagram for all formulae present in the set of 9 HS sample under study with color-coded Spearman correlation coefficient with EC50 values. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

It was found that 339 and 201 formulae possessed strong negative and positive correlation (|r| > 0.7 with p < 0.05) with EC50, respectively. Of interest is that 251 out of 339 molecular components with the strong negative correlation of EC50 were CHNO compositions. It can be deduced that the inhibitory activity is mostly related to the presence of relatively reduced aromatic compounds with H/C < 1 and O/C < 0.5. This is in agreement with the close correlation between the content of aromatic moieties and EC50 as it was revealed by the NMR data.

In search of potential structural candidates for the most active components in the humic molecular ensemble, we have mined the data for 339 highly correlated formulae (Spearman's rank correlation coefficient ≤ −0.7) in ChEMBL database. We found 792 structures and 7271 activity entries corresponding to the 112 formulae (Supplementary Info Tables S7) and 642 out of which contained N atom and 65 – S atom. The assays entries (55) and the corresponding activity entries (76) related to anti-HIV activity measurement were also retrieved (Supplementary file Table S6). Almost half of the assays included inhibition of the specific HIV protein (mostly, integrase), while the other half was presented by the assessment of antiviral activity in the cell-based assays. Several examples of the retrieved active structures, which are the derivatives of naturally occurring compounds, and corresponding activities, are presented in Table 2 . The full data are shown in Table S6 in the Supplementary Material.

Table 2.

Examples of ChEMBL compounds with anti-HIV activity corresponding to the FTICR MS formulae found in the humic materials used in this study.

Formula Structure EC50, μM assay description Ref.
C24H28O6 Image 1 1.3 Inhibition of HIV-1 induced CPE in CEM-SS cells Kashman et al. (1993)
C22H14N2O7 Image 2 0.1 Inhibition of HIV-1 induced CPE in a cell-based assay Yeo et al. (2005)
C27H21NO10 Image 3 12.5 Inhibition of HIV-1 integrase by electrochemiluminescent-based high-throughput strand transfer assay Marchand et al. (2008)
10.1 Inhibition of HIV-1 RNase H by FRET high-throughput assay Marchand et al. (2008)

Molecular formulae may correspond to a number of isomers. That is why the structural space of the active components is significantly broader as compared to molecular composition space. For deeper analysis of structures suggested for the HS components, the molecular network was plotted. ChEMBL data mining showed the presence of distinct clusters on the structural space network (Fig. 7 ). These clusters are produced by the structures with high chemical similarity – with the values of fingerprints T-score exceeding 0.8. In the most cases, the formulae assigned with the similar structures had the similar relationship to the EC50 values.

Fig. 7.

Fig. 7

Network-based representation of ChEMBL chemical space corresponding to the fomulae found in the HS samples, which were highly correlated (Spearman's rank correlation ≤ -0.7) with EC50. A network node represents chemical structure and it is labeled with the corresponding formula. An edge is drawn between a pair of nodes if the Tanimoto similarity index value was not lower than 0.8. Nodes and edges are colored by Spearman's rank correlation value. Structures presented in Table 2 are shown in green. Clusters of structures discussed in the text are highlighted by orange and their representative structures are shown. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

The largest cluster (19 nodes) is related to ether derivatives of 4′-O-demethylepipodophyllotoxins active against human DNA topoisomerase II (Zhou et al., 1991). Among the other largest clusters produced by the formulae, which are highly correlated to activity of the HS samples, there is the cluster of terpenoids from the Rhizome of Alisma orientale, tested against human Human Carboxylesterase 2 (Mai et al., 2015), and N-containing analogs of typical flavonoid – 3-O-arylmethylgalangin, active against Hepacivirus C reproduction (Lee et al., 2010). The potential structural candidates for the most active components in the humic molecular ensemble are shown in Table S6 in the Supplementary Material.

4. Conclusion

Assessment of anti-HIV activity and structure of two big sets of humic and shilajit materials allowed us to reveal the following trends. For the humic materials used in this study we have discovered two distinct trends in antiviral activity. The first one concerns much higher activity of the humic acids versus fulvic acids: HA > HMA > HFA > FA. The second trend concerns the source or origin: coal > peloid > peat. The both sequences follow the trend in lipophilicity index (a ratio of aromatic to aliphatic carbon) for these materials. This could be indicative of the leading role of the aromatic structures of HS in interaction with HIV. This assumption corroborates well the results of correlation analysis of the obtained EC50 values and structural composition: the closest relationships were observed for Car (−0.82) and CH2O (+0.7). This indicates an increase in antiviral activity along with an increase in aromaticity of HS and a decrease along with a contribution of carbohydrate moieties. The obtained results are consistent with our previous findings (Zhernov et al., 2017). The low anti-HIV activity and inverse structural trends found for the shilajit samples point out to different mode of action of shilajit materials as compared to humic substances. This is consistent with very different structural and molecular composition of shilajit as compared to humic materials.

Given the data of our reported investigations (Zhernov et al., 2017), we might suggest that the hydrophobic humic materials prevent fusion and inhibit reverse transcriptase activity of HIV-1, as it was experimentally evidenced in attachment and reverse transcriptase inhibition (RTI) assays conducted in our previous studies. These studies showed that humic materials inhibited HIV-1 reverse transcriptase in a dose-dependent manner similar to AZT. The obtained values of RTI activities of HMA and HA were well within the range determined for the mixtures of different natural lignans. We obtained the similar results in the mechanistic studies using the time-of-addition (TOA) assay with the reference inhibitors: the fusion inhibitor T-20, the reverse transcription inhibitor AZT, and the integrase inhibitor RAL (Zhernov et al., 2017). The studied hydrophobic humic materials lost 50% of their efficacy at 7–8 h post-infection (h.p.i.), which is very close to AZT (7.7 ± 0.2). This also indirectly confirms the presence of RTI-activity in hydrophobic humic materials. With regard to shilajit, we might suggest that the nitrogen-rich shilajit molecules could interfere with peptide-based attachment and act as nitrogen-fusion inhibitors. This assumption can be indirectly confirmed by the data of the same TOA assay on the nitrogen-rich peloid FA: their profile was similar to fusion inhibitor T20 with a 50% loss of efficacy reached even at 5.0 ± 0.3 h.p.i. (Zhernov et al., 2017).

In general, the obtained results demonstrate that humic materials represent a rich source of highly potent and polytargeted natural compounds which might be used for prevention and treatment of viral infections. The most promising and straightforward way of humic materials use in clinical practice can be development of anti-HIV-microbicide formulations. This would improve efficacy of prevention of HIV-1 transmission. For anti-HIV-1 therapy, humic materials may supplement the first-line treatment regimens, which so far have not included entry inhibitors. Given that humic materials can be easily produced from coal or peloids and are amenable to long-term storage at room temperature without loss of anti-HIV-1 activity, they can be used for anti-HIV-1 therapy under the resource limited settings, e.g. in the South Africa, which is strongly affected by the AIDS pandemic.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

Shilajit samples Sh29 and Sh30 were kindly provided by Prof. G.N. Pilipenko (Russian State University for Geological Prospecting). This work was partially supported by the Russian Science Foundation (project 20-63-47070) in the part of structural characterization of the humic materials used in this study, FTICR MS data-mining and chemoinformatics were supported by Russian Science Foundation [grant number 19-75-00092].

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.envres.2020.110312.

Contributors

YZ, EK and IP conceived and designed the study. AK, MS and IP provided the HS and shilajit samples. YZ and GK performed the anti-HIV activity assessment. AK performed the 13C NMR characterization and statistical calculations. AZ, AO, and EN performed the FTICR MS and 13C NMR characterization, data-mining and chemometrics of the samples. EN, EK and IP supervised the study. AK, AZ, AO, MS, GK and YZ drafted the manuscript. All authors read and approved the final manuscript.

Funding

This work was partially supported by the Russian Science Foundation (project 20-63-47070) in the part of structural characterization of the humic materials used in this study. FTICR MS data-mining and chemometrics were supported by Russian Science Foundation [grant number 19-75-00092].

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Multimedia component 1
mmc1.xlsx (250.8KB, xlsx)
Multimedia component 2
mmc2.xlsx (2.6MB, xlsx)
Multimedia component 3
mmc3.xls (1MB, xls)
Multimedia component 4
mmc4.docx (508.1KB, docx)

References

  1. Agarwal S.P., Khanna R., Karmarkar R., Anwer M.K., Khar R.K. Shilajit: a review. Phyther. Res. 2007;21:401–405. doi: 10.1002/ptr.2100. [DOI] [PubMed] [Google Scholar]
  2. Andrae-Marobela K., Ghislain F.W., Okatch H., Majinda R.R.T. Polyphenols: a diverse class of multi-target anti-HIV-1 agents. Curr. Drug Metabol. 2013;14:392–413. doi: 10.2174/13892002113149990095. [DOI] [PubMed] [Google Scholar]
  3. Botes M.E., Dekker J., van Rensburg C.E.J. Phase I trial with oral Oxihumate in HIV-infected patients. Drug Dev. Res. 2002;57:34–39. doi: 10.1002/ddr.10117. [DOI] [Google Scholar]
  4. Bruccoleri A. Positional adaptability in the design of mutation-resistant nonnucleoside HIV-1 reverse transcriptase inhibitors: a supramolecular perspective. AIDS Res. Hum. Retrovir. 2013;29:4–12. doi: 10.1089/AID.2012.0141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cagno V., Donalisio M., Civra A., Cagliero C., Rubiolo P., Lembo D. In vitro evaluation of the antiviral properties of Shilajit and investigation of its mechanisms of action. J. Ethnopharmacol. 2015;166:129–134. doi: 10.1016/j.jep.2015.03.019. [DOI] [PubMed] [Google Scholar]
  6. Daglia M. Polyphenols as antimicrobial agents. Curr. Opin. Biotechnol. 2012;23:174–181. doi: 10.1016/j.copbio.2011.08.007. [DOI] [PubMed] [Google Scholar]
  7. Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020;20:533–534. doi: 10.1016/S1473-3099(20)30120-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dong G., Peng C., Luo J., Wang C., Han L., Wu B., Ji G., He H. Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations. PloS One. 2015;10 doi: 10.1371/journal.pone.0119115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fedoros E.I., Orlov A.A., Zherebker A., Gubareva E.A., Maydin M.A., Konstantinov A.I., Krasnov K.A., Karapetian R.N., Izotova E.I., Pigarev S.E., Panchenko A.V., Tyndyk M.L., Osolodkin D.I., Nikolaev E.N., Perminova I.V., Anisimov V.N. Novel water-soluble lignin derivative BP-Cx-1: identification of components and screening of potential targets in silico and in vitro. Oncotarget. 2018;9:18578–18593. doi: 10.18632/oncotarget.24990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ford N., Vitoria M., Rangaraj A., Norris S.L., Calmy A., Doherty M. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment. J. Int. AIDS Soc. 2020;23 doi: 10.1002/jia2.25489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Helbig B., Klöcking R., Wutzler P. Anti-herpes simplex virus type 1 activity of humic acid-like polymers and their o-diphenolic starting compounds. Antivir. Chem. Chemother. 1997;8:265–273. doi: 10.1177/095632029700800310. [DOI] [PubMed] [Google Scholar]
  12. Hertkorn N., Permin A., Perminova I., Kovalevskii D., Yudov M., Petrosyan V., Kettrup A. Comparative analysis of partial structures of a peat humic and fulvic acid using one- and two-dimensional nuclear magnetic resonance spectroscopy. J. Environ. Qual. 2002;31:375–387. doi: 10.2134/jeq2002.3750. [DOI] [PubMed] [Google Scholar]
  13. Jeeninga R.E., Keulen W., Boucher C., Sanders R.W., Berkhout B. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in Vivo has a replication defect. Virology. 2001;283:294–305. doi: 10.1006/viro.2001.0888. [DOI] [PubMed] [Google Scholar]
  14. Jooné G.K., Dekker J., Van Rensburg C.E.J. Investigation of the immunostimulatory properties of oxihumate. Zeitschrift fur Naturforsch. - Sect. C J. Biosci. 2003;58:263–267. doi: 10.1515/znc-2003-3-421. [DOI] [PubMed] [Google Scholar]
  15. Karamov E., Epremyan K., Siniavin A., Zhernov Y., Cuevas M.T., Delgado E., Sánchez-Martínez M., Carrera C., Kornilaeva G., Turgiev A., Bacqué J., Pérez-Álvarez L., Thomson M.M. HIV-1 genetic diversity in recently diagnosed infections in Moscow: predominance of A FSU , frequent branching in clusters, and circulation of the Iberian subtype G variant. AIDS Res. Hum. Retrovir. 2018;34:629–634. doi: 10.1089/aid.2018.0055. [DOI] [PubMed] [Google Scholar]
  16. Kashman Y., Gustafson K.R., Fuller R.W., Cardellina J.H., McMahon J.B., Currens M.J., Buckheit R.W., Hughes S.H., Cragg G.M., Boyd M.R. HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. [Erratum to document cited in CA117(11):108101g] J. Med. Chem. 1993;36:1110. doi: 10.1021/jm00060a020. [DOI] [PubMed] [Google Scholar]
  17. Khanna R., Witt M., Anwer M., Agarwal S.P., Koch B.P. Spectroscopic characterization of fulvic acids extracted from the rock exudate Shilajit. Org. Geochem. 2008;39:1719–1724. [Google Scholar]
  18. Klöcking R., Helbig B., Schötz G., Schacke M., Wutzler P. Anti-HSV-1 activity of synthetic humic acid-like polymers derived from p-diphenolic starting com-pounds. Antivir. Chem. Chemother. 2002;13:241–249. doi: 10.1177/095632020201300405. [DOI] [PubMed] [Google Scholar]
  19. Klöcking R., Sprössig M. Antiviral properties of humic acids. Experientia. 1972;28:607–608. doi: 10.1007/BF01931906. [DOI] [PubMed] [Google Scholar]
  20. Koch B.P., Dittmar T. From mass to structure: an aromaticity index for high-resolution mass data of natural organic matter. Rapid Commun. Mass Spectrom. 2006;20:926–932. doi: 10.1002/rcm.2386. [DOI] [Google Scholar]
  21. Koch B.P., Dittmar T. Erratum. From mass to structure: an aromaticity index for high-resolution mass data of natural organic matter. Rapid Commun. Mass Spectrom. 2016;30 doi: 10.1002/rcm.7433. 250-250. [DOI] [Google Scholar]
  22. Konstantinov A.I., Vladimirov G.N., Grigoryev A.S., Kudryavtsev A.V., Perminova I.V., Nikolaev E.N. In: Functions of Natural Organic Matter in Changing Environment. Xu J., Wu J., He Y., editors. Springer; Dordrecht: 2013. Molecular composition study of Mumijo from different geographic areas using size-exclusion chromatography, NMR spectroscopy, and high-resolution mass spectrometry; pp. 283–287. [DOI] [Google Scholar]
  23. Kornilaeva G.V., Siniavin A.E., Schultz A., Germann A., Moog C., von Briesen H., Turgiev A.S., Karamov E.V. The differential anti-HIV effect of a new humic substance-derived preparation in diverse cells of the immune system. Acta Naturae. 2019;11:68–76. doi: 10.32607/20758251-2019-11-2-68-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kovalevskii D.V., Permin A.B., Perminova I.V., Petrosyan V.S. Recovery of conditions for quantitative measuring the PMR spectra of humic acids. Moscow Univ. Chem. Bull. 2000;41:39–42. [Google Scholar]
  25. Kunenkov E.V., Kononikhin A.S., Perminova I.V., Hertkorn N., Gaspar A., Schmitt-Kopplin P., Popov I.A., Garmash A.V., Nikolaev E.N. Total mass difference statistics algorithm: a new approach to identification of high-mass building blocks in electrospray ionization fourier transform ion cyclotron mass spectrometry data of natural organic matter. Anal. Chem. 2009;81:10106–10115. doi: 10.1021/ac901476u. [DOI] [PubMed] [Google Scholar]
  26. Lee H.S., Park K.S., Lee B., Kim D.E., Chong Y. 3-O-arylmethylgalangin, a novel isostere for anti-HCV 1,3-diketoacids (DKAs) Bioorg. Med. Chem. 2010;18:7331–7337. doi: 10.1016/j.bmc.2010.09.021. [DOI] [PubMed] [Google Scholar]
  27. Leefmann T., Frickenhaus S., Koch B.P. UltraMassExplorer: a browser-based application for the evaluation of high-resolution mass spectrometric data. Rapid Commun. Mass Spectrom. 2019;33:193–202. doi: 10.1002/rcm.8315. [DOI] [PubMed] [Google Scholar]
  28. Leydet A., Moullet C., Roque J.P., Witvrouw M., Pannecouque C., Andrei G., Snoeck R., Neyts J., Schols D., De Clercq E.J. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission. J. Med. Chem. 1998;41:4927–4932. doi: 10.1021/jm970661f. [DOI] [PubMed] [Google Scholar]
  29. Li G., De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat. Rev. Drug Discov. 2020;19:149–150. doi: 10.1038/d41573-020-00016-0. [DOI] [PubMed] [Google Scholar]
  30. Lu F.J., Tseng S.N., Li M.L., Shih S.R. In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid. Arch. Virol. 2002;147:273–284. doi: 10.1007/s705-002-8319-5. [DOI] [PubMed] [Google Scholar]
  31. Mai Z.P., Zhou K., Ge G.B., Wang C., Huo X.K., Dong P.P., Deng S., Zhang B.J., Zhang H.L., Huang S.S., Ma X.C. Protostane triterpenoids from the Rhizome of Alisma orientale exhibit inhibitory effects on human Carboxylesterase 2. J. Nat. Prod. 2015;78:2372–2380. doi: 10.1021/acs.jnatprod.5b00321. [DOI] [PubMed] [Google Scholar]
  32. Marchand C., Beutler J.A., Wamiru A., Budihas S., Möllmann U., Heinisch L., Mellors J.W., Le Grice S.F., Pommier Y. Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H. Antimicrob. Agents Chemother. 2008;52:361–364. doi: 10.1128/AAC.00883-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Moskaleychik F.F., Laga V.Y., Delgado E., Vega Y., Fernandez-Garcia A., Perez-Alvarez, Kornilaeva G.V., Pronin A.Y., Zhernov Y.V., Thomson M.M., Bobkova M.R., Karamov E.V. Rapid spread of the HIV-1 circular recombinant CRF02-AG in Russia and neighboring countries. Vopr. Virusol. 2015;60:14–19. [PubMed] [Google Scholar]
  34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  35. Nikolaev E.N., Boldin I.A., Jertz R., Baykut G. Initial experimental characterization of a new ultra-high resolution FTICR cell with dynamic harmonization. J. Am. Soc. Mass Spectrom. 2011;22:1125–1133. doi: 10.1007/s13361-011-0125-9. [DOI] [PubMed] [Google Scholar]
  36. Orlov A.A., Zherebker A., Eletskaya A.A., Chernikov V.S., Kozlovskaya L.I., Zhernov Y.V., Kostyukevich Y., Palyulin V.A., Nikolaev E.N., Osolodkin D.I., Perminova I.V. Examination of molecular space and feasible structures of bioactive components of humic substances by FTICR MS data mining in ChEMBL database. Sci. Rep. 2019;9:12066. doi: 10.1038/s41598-019-48000-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pottage J.C., Kessler H.A. Herpes simplex virus resistance to acyclovir: clinical relevance. Infect. Agents Dis. 1995;4:115–124. [PubMed] [Google Scholar]
  38. Sander T., Freyss J., von Korff M., Rufener C. DataWarrior: an open-source program for chemistry aware data visualization and analysis. J. Chem. Inf. Model. 2015;55:460–473. doi: 10.1021/ci500588j. [DOI] [PubMed] [Google Scholar]
  39. Savage A.M., Li Y., Matolyak L.E., Doncel G.F., Turner S.R., Gandour R.D. Anti-HIV activities of precisely defined, semirigid, carboxylated alternating copolymers. J. Med. Chem. 2014;57:6354–6363. doi: 10.1021/jm401913w. [DOI] [PubMed] [Google Scholar]
  40. Schneider J., Weis R., Männer C., Kary B., Werner A., Seubert B.J., Riede U.N. Inhibition of HIV-1 in cell culture by synthetic humate analogues derived from hydroquinone: mechanism of inhibition. Virology. 1996;218:389–395. doi: 10.1006/viro.1996.0208. [DOI] [PubMed] [Google Scholar]
  41. Schepetkin I.A., Khlebnikov A.I., Ah S.Y., Woo S.B., Jeong C.S., Klubachuk O.N., Kwon B.S. Characterization and biological activities of humic substances from mumie. J. Agric. Food Chem. 2003;51:5245–5254. doi: 10.1021/jf021101e. [DOI] [PubMed] [Google Scholar]
  42. Schepetkin I.A., Xie G., Mark A., Jutila M.A., Quinn M.T. Complement-fixing activity of fulvic acid from shilajit and other natural sources. Phytother Res. 2009;23:373–384. doi: 10.1002/ptr.2635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schols D., Wutzler P., Klöcking R., Helbig B., De E.C. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication. J. Acquir. Immune Defic. Syndr. 1991;4:677–685. [PubMed] [Google Scholar]
  44. Sleighter R.L., Hatcher P.G. The application of electrospray ionization coupled to ultrahigh resolution mass spectrometry for the molecular characterization of natural organic matter. J. Mass Spectrom. 2007;42:559–574. doi: 10.1002/jms.1221. [DOI] [PubMed] [Google Scholar]
  45. Sleighter R.L., Mckee G.A., Liu Z., Hatcher P.G. Naturally present fatty acids as internal calibrants for fourier transform mass spectra of dissolved organic matter. Limnol Oceanogr. Methods. 2008;6:246–253. doi: 10.4319/lom.2008.6.246. [DOI] [Google Scholar]
  46. Stevenson F. second ed. Wiley and Sons; New York, NY: 1994. Humus Chemistry: Genesis, Composition, Reactions. Humus Chem. [Google Scholar]
  47. Van Rensburg C.E.J., Dekker J., Weis R., Smith T.L., Janse Van Rensburg E., Schneider J. Investigation of the anti-HIV properties of oxihumate. Chemotherapy. 2002;48:138–143. doi: 10.1159/000064919. [DOI] [PubMed] [Google Scholar]
  48. Wain-Hobson S., Vartanian J.P., Henry M., Chenciner N., Cheynier R., Delassus S., Martins L.P., Sala M., Nugeyre M.T., Guétard D., Klatzmann D., Gluckman J.C., Rozenbaum W., Barré-Sinoussi F., Montagnier L. LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science. 1991;252:961–965. doi: 10.1126/science.2035026. [DOI] [PubMed] [Google Scholar]
  49. Yeo H., Li Y., Fu L., Zhu J.L., Gullen E.A., Dutschman G.E., Lee Y., Chung R., Huang E.S., Austin D.J., Cheng Y.C. Synthesis and antiviral activity of helioxanthin analogues. J. Med. Chem. 2005;48:534–546. doi: 10.1021/jm034265a. [DOI] [PubMed] [Google Scholar]
  50. Zhan P., Pannecouque C., De Clercq E., Liu X. Anti-HIV drug discovery and development: current innovations and future trends. J. Med. Chem. 2016;59:2849–2878. doi: 10.1021/acs.jmedchem.5b00497. [DOI] [PubMed] [Google Scholar]
  51. Zherebker A., Turkova A.V., Kostyukevich Y., Kononikhin A., Zaitsev K.V., Popov I.A., Nikolaev E., Perminova I.V. Synthesis of carboxylated styrene polymer for internal calibration of Fourier transform ion cyclotron resonance mass-spectrometry of humic substances. Eur. J. Mass Spectrom. 2017;23:156–161. doi: 10.1177/1469066717718963. [DOI] [PubMed] [Google Scholar]
  52. Zherebker A.Y., Airapetyan D., Konstantinov A.I., Kostyukevich Y.I., Kononikhin A.S., Popov I.A., Zaitsev K.V., Nikolaev E.N., Perminova I.V. Synthesis of model humic substances: a mechanistic study using controllable H/D exchange and Fourier transform ion cyclotron resonance mass spectrometry. Analyst. 2015;140:4708–4719. doi: 10.1039/c5an00602c. [DOI] [PubMed] [Google Scholar]
  53. Zhernov Y. Natural humic substances interfere with multiple stages of the replication cycle of human immunodeficiency virus. J. Allergy Clin. Immunol. 2018;141:AB233. doi: 10.1016/j.jaci.2017.12.737. [DOI] [Google Scholar]
  54. Zhernov Y.V., Khaitov M.R. Microbicides for topical immunoprevention of HIV infection (in Russ) Bull. Sib. Med. 2019;18:49–59. doi: 10.20538/1682-0363-2019-1-49-59. [DOI] [Google Scholar]
  55. Zhernov Y.V., Kremb S., Helfer M., Schindler M., Harir M., Mueller C., Hertkorn N., Avvakumova N.P., Konstantinov A.I., Brack-Werner R., Schmitt-Kopplin P., Perminova I.V. Supramolecular combinations of humic polyanions as potent microbicides with polymodal anti-HIV-activities. New J. Chem. 2017;41:212–224. doi: 10.1039/C6NJ00960C. [DOI] [Google Scholar]
  56. Zhou X.M., Wang Z.Q., Chang J.Y., Chen H.X., Cheng Y.C., Lee K.H. Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II. J. Med. Chem. 1991;34:3346–3350. doi: 10.1021/jm00116a001. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.xlsx (250.8KB, xlsx)
Multimedia component 2
mmc2.xlsx (2.6MB, xlsx)
Multimedia component 3
mmc3.xls (1MB, xls)
Multimedia component 4
mmc4.docx (508.1KB, docx)

Articles from Environmental Research are provided here courtesy of Elsevier

RESOURCES